Phase I Clinical Trial of Ixabepilone and Pemetrexed in Advanced Solid Tumors.

Trial Profile

Phase I Clinical Trial of Ixabepilone and Pemetrexed in Advanced Solid Tumors.

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 24 Jan 2014

At a glance

  • Drugs Ixabepilone (Primary) ; Pemetrexed (Primary)
  • Indications Advanced breast cancer; Cervical cancer; Lung cancer; Mesothelioma; Ovarian cancer; Prostate cancer; Solid tumours; Uterine cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 05 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top